Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal contraceptives are highly effective but require medical evaluation due to potential health risks.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

Antiandrogenic treatments can effectively manage certain skin conditions by using female hormones.

Oral contraceptives can affect skin and hair, improve acne, but may cause pigmentation, dermatitis, and other conditions.

Androgens affect skin conditions like acne and hirsutism, treatable with hormone therapy and other methods.

Contraceptives may affect hair growth due to estrogen, with effects varying by individual.

Doctors recommend postoperative radiation for male breast cancer, advise against testosterone for vasomotor symptoms post-adrenalectomy, suggest non-hormonal treatments for atrophic vaginitis after mastectomy, note no specific treatment for anticoagulant-induced hair loss, and call for more research on silicosis from silicon carbide exposure.

Reassurance is important for postpartum hair shedding as it likely won't cause complete baldness.

Treatments for hair loss include estrogen therapy and special shampoos.

Ferulic acid may help control menstrual cycle-related epilepsy by affecting female hormones.

Finasteride may cause sexual dysfunction by reducing epinephrine levels.

Estradiol-rich plasma can increase hair density faster and more effectively in male pattern baldness treatment than regular plasma.

Genetics, low estrogen, and low iron levels contribute to female hair loss, with specific scalp signs indicating severity.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

New treatments for male hypogonadism are effective and should be personalized.

Hormonal contraceptives and related compounds can increase health risks like thrombosis and affect sexual function.

Chemoprevention, using drugs like finasteride and dutasteride, can help prevent prostate cancer.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

Smoking may contribute to hair loss in men.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Using anabolic-androgenic steroids can harm men's reproductive health and increase the risk of heart problems and death.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Hormonal imbalance contributes to chronic prostatitis and affects male reproductive health.

Cirrhosis affects quality of life with various symptoms, requiring a holistic, multidisciplinary approach for management.

A man's breast enlargement from low-dose finasteride for hair loss didn't go away, even with treatment, and might be more common than reported.

The document suggests using trazodone and clomiphene to treat sexual dysfunction caused by post-finasteride syndrome.

If a dog's skin tests are normal but it has hair loss, consider other non-endocrine causes and choose tests based on the hair loss pattern.